SAN DIEGO, Nov. 24, 2025 /PRNewswire/ — Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a Notice of Intention to Grant for European…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
